FindTrial
Sign In

The study on the correlation between drug genetic polymorphisms in the Hunan population and the levels of TMAO and other biomarkers

The study on the correlation between drug genetic polymorphisms in the Hunan population and the levels of TMAO and other biomarkers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094028
Enrollment
Unknown
Registered
2024-12-16
Start date
2023-09-19
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

biomarker

Interventions

Trail group:None

Sponsors

The Third Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age: Over 18 years old; 2. Willingly sign an informed consent form and complete a survey questionnaire.

Exclusion criteria

Exclusion criteria: 1. (Interview) Those who cannot tolerate venipuncture and/or have a history of fainting at the sight of blood or needles; 2. (Laboratory Test) Blood routine test samples that are infectious; 3. Those who may not be able to provide samples for other reasons.

Design outcomes

Primary

MeasureTime frame
Trimethylamine N-oxide;Phenylacetylglutamine;—

Countries

China

Contacts

Public ContactZhang Di

The Third Xiangya Hospital of Central South University

10416475@qq.com+86 139 7580 4690

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026